Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis

ClinicalTrials.gov ID: NCT00069186

Public ClinicalTrials.gov record NCT00069186. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multi-Center, Double-Blind, Placebo Controlled, Randomized Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine whether nine months of administration of creatine monohydrate results in an increase in muscle strength in patients with amyotrophic lateral sclerosis (ALS).

Study identification

NCT ID: NCT00069186
Recruitment status: Not listed
Study type: Interventional
Phase: Phase 3
Lead sponsor: The Avicena Group; Industry
Enrollment: 107 participants

Conditions and interventions

Conditions

Amyotrophic Lateral Sclerosis (ALS)

Interventions

Creatine Monohydrate Drug

Drug

Eligibility (public fields only)

Age range: 21 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 31, 2003
Primary completion: Not listed
Completion: Mar 31, 2005
Last update posted: Jun 23, 2005

2003 – 2005

United States locations

U.S. sites: 8
U.S. states: 7
U.S. cities: 8

Facility	City	State	ZIP	Site status
University of California, San Francisco	San Francisco	California	94115	—
University of Kansas	Kansas City	Kansas	66160	—
University of New Mexico	Albuquerque	New Mexico	87131	—
Carolinas Medical Center	Charlotte	North Carolina	28203-5812	—
Duke University Medical Center	Durham	North Carolina	27705	—
Oregon Health Sciences University	Portland	Oregon	97239	—
University of Texas Health Science Center	San Antonio	Texas	48284-7883	—
University of Virginia Health System	Charlottesville	Virginia	22908	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00069186, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 23, 2005 · Synced Sep 2, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00069186 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →